Brief: Carl Zeiss Meditec Says ILM-Blue From DORC Gets NMPA Approval In China
27/03/2025 08:09
March 27 (Reuters) - Carl Zeiss Meditec AG AFXG.DE: ILM-BLUE FROM DORC RECEIVES NMPA APPROVAL IN CHINA Source text: ID:nPreVXKmJa Further company coverage: AFXG.DE (Gdansk newsroom) (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on Carl Zeiss Meditec AG
See all newsBrief: Zeiss Launches CT LUCIA 621P Cataract Lens In Japan
Europe Research Roundup: Bankinter, Santander, Volex
Corrected: ANALYSIS-ASML's 'sold out' outlook forces investors to look beyond demand
Brief: Carl Zeiss Meditec Acquires Ceres Holographics
Carl Zeiss Meditec falls after GS cuts to 'sell' on valuation concerns